3-(1-Oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione hydrochloride, 98%, 1g

3-Fluoro-4-nitrotoluene>98.0%(GC)5g

4-(4-Methylphenyl)piperidine hydrochloride, 95+%, 1g

(2R,3R,4S,5R)-2,3,4,6-Tetrahydroxy-5-mercaptohexanal, 95.0%, 1g

2-Amino-3-bromo-5-chloro-6-fluorobenzonitrile, 95.0%, 5g

TERT-BUTYL ((3-AMINOBICYCLO[1.1.1]PENTAN-1-YL)METHYL)CARBAMATE, 95.0%, 500mg

tert-Butyl ((3R,4R,5S)-4-((tert-butyldimethylsilyl)oxy)-5-methylpiperidin-3-yl)carbamate, 97%, 500mg

Liothyronine, 95+%, 500mg

Ethyl 2-((tert-butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate, 97%, 1g

1,3,3-Trimethyl-6'-morpholinospiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine], 97%, 1g

Contenitori per reagenti Contenuto 100 ml, non sterile, 10 x 10, 100 pezzi, 100 pezzi

4,5-Dibromo-2-furoic acid, 95.0%, 25g

rel-(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carboxylic acid tert-butyl ester, 97%, 100mg